ID

40345

Descripción

Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension?; ODM derived from: https://clinicaltrials.gov/show/NCT02237339

Link

https://clinicaltrials.gov/show/NCT02237339

Palabras clave

Versiones (1)
  1. 10/4/20 10/4/20 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

10 de abril de 2020

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Hypertension NCT02237339

Inglés

Eligibility Hypertension NCT02237339

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
are aged over 18 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
previously diagnosed with essential hypertension
Descripción

Essential Hypertension

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0085580
been on stable antihypertensive therapy for at least 3 months prior to study screening
Descripción

Antihypertensive therapy Stable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0585941
UMLS CUI [1,2]
C0205360
have screening ambulatory bloods pressure monitoring (abpm) or home based bp monitoring if abpm not tolerated with daytime average systolic <135mmhg
Descripción

Blood Pressure Monitoring, Ambulatory | Blood Pressure Monitoring, Home | Systolic Pressure Daytime Average

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0242876
UMLS CUI [2]
C1449681
UMLS CUI [3,1]
C0871470
UMLS CUI [3,2]
C0332169
UMLS CUI [3,3]
C1510992
have screening echocardiography based diagnosis of left ventricular hypertrophy (lvh) based on american society of echocardiography (ase) criteria (males >115g/m2, females >95g/m2)
Descripción

Left Ventricular Hypertrophy Echocardiography | Gender

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0149721
UMLS CUI [1,2]
C0013516
UMLS CUI [2]
C0079399
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
documented intolerance to allopurinol
Descripción

Intolerance to Allopurinol

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0002144
left ventricular ejection fraction <45% on echocardiography screening
Descripción

Left ventricular ejection fraction Echocardiography

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0428772
UMLS CUI [1,2]
C0013516
severe aortic stenosis on echocardiography screening
Descripción

Severe aortic stenosis Echocardiography

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3806272
UMLS CUI [1,2]
C0013516
active gout (i.e. flare within two years) or currently on allopurinol
Descripción

Gout | Gout flare | Allopurinol

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018099
UMLS CUI [2]
C1619733
UMLS CUI [3]
C0002144
severe hepatic disease
Descripción

Liver disease Severe

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0205082
renal disease; chronic kidney disease (ckd) class 3b or worse
Descripción

Kidney Disease | Chronic Kidney Disease Stage

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0022658
UMLS CUI [2,1]
C1561643
UMLS CUI [2,2]
C2074731
on azathioprine, 6 mercaptopurine, or theophylline
Descripción

Azathioprine | mercaptopurine | Theophylline

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004482
UMLS CUI [2]
C0000618
UMLS CUI [3]
C0039771
malignancy (receiving active treatment) or other life threatening diseases
Descripción

Malignant Neoplasms | Cancer treatment | Life threatening illness

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0920425
UMLS CUI [3]
C3846017
pregnant or lactating women
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
any contraindication to magnetic resonance imaging (mri) (claustrophobia, metal implants, penetrative eye injury or exposure to metal fragments in eye requiring medical attention).
Descripción

Medical contraindication Magnetic Resonance Imaging | Claustrophobia | Metallic implant | Eye Injuries, Penetrating | Exposure to Metal foreign body in eye region

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0024485
UMLS CUI [2]
C0008909
UMLS CUI [3]
C3693688
UMLS CUI [4]
C0015409
UMLS CUI [5,1]
C0332157
UMLS CUI [5,2]
C0562528
patients who have participated in any other clinical trial of an investigational medicinal product within the previous 30 days will be excluded.
Descripción

Study Subject Participation Status | Clinical Trial | Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0008976
UMLS CUI [3]
C0013230
patients who are unable to give informed consent
Descripción

Informed Consent Unable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
any other considered by a study physician to be inappropriate for inclusion.
Descripción

Study Subject Participation Status Inappropriate

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1548788
Volver a la parte superior de la página

Similar models

Eligibility Hypertension NCT02237339

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
are aged over 18 years
boolean
C0001779 (UMLS CUI [1])
Essential Hypertension
Item
previously diagnosed with essential hypertension
boolean
C0085580 (UMLS CUI [1])
Antihypertensive therapy Stable
Item
been on stable antihypertensive therapy for at least 3 months prior to study screening
boolean
C0585941 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
Blood Pressure Monitoring, Ambulatory | Blood Pressure Monitoring, Home | Systolic Pressure Daytime Average
Item
have screening ambulatory bloods pressure monitoring (abpm) or home based bp monitoring if abpm not tolerated with daytime average systolic <135mmhg
boolean
C0242876 (UMLS CUI [1])
C1449681 (UMLS CUI [2])
C0871470 (UMLS CUI [3,1])
C0332169 (UMLS CUI [3,2])
C1510992 (UMLS CUI [3,3])
Left Ventricular Hypertrophy Echocardiography | Gender
Item
have screening echocardiography based diagnosis of left ventricular hypertrophy (lvh) based on american society of echocardiography (ase) criteria (males >115g/m2, females >95g/m2)
boolean
C0149721 (UMLS CUI [1,1])
C0013516 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Intolerance to Allopurinol
Item
documented intolerance to allopurinol
boolean
C1744706 (UMLS CUI [1,1])
C0002144 (UMLS CUI [1,2])
Left ventricular ejection fraction Echocardiography
Item
left ventricular ejection fraction <45% on echocardiography screening
boolean
C0428772 (UMLS CUI [1,1])
C0013516 (UMLS CUI [1,2])
Severe aortic stenosis Echocardiography
Item
severe aortic stenosis on echocardiography screening
boolean
C3806272 (UMLS CUI [1,1])
C0013516 (UMLS CUI [1,2])
Gout | Gout flare | Allopurinol
Item
active gout (i.e. flare within two years) or currently on allopurinol
boolean
C0018099 (UMLS CUI [1])
C1619733 (UMLS CUI [2])
C0002144 (UMLS CUI [3])
Liver disease Severe
Item
severe hepatic disease
boolean
C0023895 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Kidney Disease | Chronic Kidney Disease Stage
Item
renal disease; chronic kidney disease (ckd) class 3b or worse
boolean
C0022658 (UMLS CUI [1])
C1561643 (UMLS CUI [2,1])
C2074731 (UMLS CUI [2,2])
Azathioprine | mercaptopurine | Theophylline
Item
on azathioprine, 6 mercaptopurine, or theophylline
boolean
C0004482 (UMLS CUI [1])
C0000618 (UMLS CUI [2])
C0039771 (UMLS CUI [3])
Malignant Neoplasms | Cancer treatment | Life threatening illness
Item
malignancy (receiving active treatment) or other life threatening diseases
boolean
C0006826 (UMLS CUI [1])
C0920425 (UMLS CUI [2])
C3846017 (UMLS CUI [3])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Medical contraindication Magnetic Resonance Imaging | Claustrophobia | Metallic implant | Eye Injuries, Penetrating | Exposure to Metal foreign body in eye region
Item
any contraindication to magnetic resonance imaging (mri) (claustrophobia, metal implants, penetrative eye injury or exposure to metal fragments in eye requiring medical attention).
boolean
C1301624 (UMLS CUI [1,1])
C0024485 (UMLS CUI [1,2])
C0008909 (UMLS CUI [2])
C3693688 (UMLS CUI [3])
C0015409 (UMLS CUI [4])
C0332157 (UMLS CUI [5,1])
C0562528 (UMLS CUI [5,2])
Study Subject Participation Status | Clinical Trial | Investigational New Drugs
Item
patients who have participated in any other clinical trial of an investigational medicinal product within the previous 30 days will be excluded.
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2])
C0013230 (UMLS CUI [3])
Informed Consent Unable
Item
patients who are unable to give informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Study Subject Participation Status Inappropriate
Item
any other considered by a study physician to be inappropriate for inclusion.
boolean
C2348568 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial